Published in Drug Week, October 14th, 2011
"The aim of this study was to evaluate the effects of LTA-induced PI3K activation in HGFs. We found that LTA treatment results in the phosphorylation of Ala and glycogen synthase kinase (GSK-3). Inactivation of GSK-3 promotes the nuclear accumulation of beta-catenin and expression of connexin43. Treatment with PI3K inhibitors,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.